Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging Evidence

SIMPLE SUMMARY: Gastroesophageal cancers (GEC) constitute a common group of tumors that vary highly in incidence and treatment response. Although chemotherapy is the mainstay of treatment, immunotherapy with immune-checkpoint inhibitors (ICI) is a novel treatment modality for this type of cancer. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Paydary, Koosha, Reizine, Natalie, Catenacci, Daniel V. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656762/
https://www.ncbi.nlm.nih.gov/pubmed/34885039
http://dx.doi.org/10.3390/cancers13235929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656762/
https://www.ncbi.nlm.nih.gov/pubmed/34885039
http://dx.doi.org/10.3390/cancers13235929

Ejemplares similares